E32
American Journal of Infection Control June 2011
Education, reeducation and compliance monitoring are also instrumental in infection prevention strategies, reducing morbidity and reducing healthcare costs. Presentation Number 13-135
Transparent Chlorhexidine (CHG) IV Securement Dressing vs. Chlorhexidine (CHG) Impregnated Disk Patricia Gould, RN, Infection Preventionist, St. Joseph Mercy Health Center, Hot Springs, AR Background: St. Joseph’s Mercy Health Center is a 293 bed facility located in Hot Springs, AR. Despite compliance with guidelines and evidence based ‘‘bundles’’, the Peripherally Inserted Central Catheter (PICC) rate was 1.40 per 1,000 PICC line days prior to study. Prior dressing consisted of a CHG impregnated disk, securement device and a transparent dressing at insertion and then changed every Sunday or if dressing became loose or soiled. Objective: Objective was to save lives, decrease cost and length of stay by reducing the number of PICC line CLABSIs with a target of zero. Methods: The NHSN/CDC1 definition of CLABSI was used to determine if patients met criteria for CLABSI. All patients with a PICC line were included in the study. The dressing change protocol of using a transparent chlorhexidine IV securement dressing at insertion and change every Sunday or if dressing became loose or soiled was implemented in the critical care unit on January 1, 2009 and housewide on April 1, 2009. Compliance with transparent CHG IV securement dressing was monitored daily by charge nurse when rounding to count for line days. Results: Compliance with transparent IV securement was 100%. PICC line CLABSI rate has decreased from 1.40 per 1,000 PICC line days with the CHG impregnated disk to 0.48 per 1,000 PICC line days with the transparent CHG securement dressing. There have been no adverse reactions reported. Staff and physician satisfaction has played a very important role in compliance with the dressing. Conclusion: The results of the study suggests that the transparent CHG IV securement dressing compared to the CHG impregnated disk, decreased the PICC line CLABSI rate from 1.40 per 1,000 PICC line days with the CHG impregnated disk to 0.48 per 1,000 PICC line days with the transparent CHG IV securement dressing. Reference: 1Teresa C. Horan, MPH, Mary Andrus, RN, BA, CIC, and Margaret A. Dudeck, MPH Atlanta, Georgia. CDC/NHSN surveillance definition of healthcare associated infection and criteria for specific types of infection in the acute care setting. Am J Infect Control (2008): 309-332. Presentation Number 13-136
Higher Access-Associated Bacteremia but Less Hospitalization Among Saudi Compared To US Hemodialysis Outpatients Aiman El-Saed, MD, PhD, Epidemiologist and Biostatistician; Abdullah Sayyari, MD, PhD, Chairman, Division of Nephrology & Renal Transplantation; Fayez Hejaili, MD, Consultant, Division of Nephrology & Renal Transplantation; Mahmoud Sallah, MD, Consultant, Department of Infection Prevention and Control; Nimfa Dagunton, CIC, Infection Control Professional, Department of Infection Prevention and Control; Hanan Balkhy, MD, Executive Director, Department of Infection Prevention and Control; King Abdulaziz Medical City, Riyadh, Saudi Arabia Background: There has been a constant increase in the number of hemodialysis patients over the last few decades in Saudi Arabia, with about 11,000 patients are currently treated. Few reports examined common morbidity problems among hemodialysis patients including hospitalization and septicemia. However, there has been a lack of data estimating standardized rates of adverse events, including access-associated bacteremia and the need of intravenous antimicrobial, to allow benchmarking.